GPT Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 ,inter alia, to consider and approve 1. the Unaudited Financial Results along with Limited Review Report of the Statutory Auditors thereon of the Company for the 2nd quarter and half year ended on September 30, 2026 2.the declaration of interim dividend for the FY 2026-27, if any, on the equity share capital of the company.

GPT Healthcare Limited Regd. Office: GPT Centre, JC-25, Sector III, Salt Lake, Kolkata – 700 106, India CIN : L70101WB1989PLC047402 Phone : +91-33-4050-7000, Email : info@gptgroup.co.in , Visit us: www.gptgroup.co.in GPTHEALTH/CS/SE/2026-27 October 27, 2026 The Department of Corporate Services National Stock Exchange of India Limited BSE Limited, Exchange Plaza, Plot no. C/1, G Block, Phiroze Jeejeebhoy Towers, Bandra-Kurla Complex, Bandra (E), Dalal Street Mumbai - 400 051 Mumbai – 400001 Scrip Symbol: GPTHEALTH Scrip Code: 544131 ISIN: INE486R01017 Dear Sir/Madam Subject: Intimation of Board Meeting pursuant to Regulations 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Notice is hereby given that a meeting of the Board of Directors of the Company is scheduled to be held on Thursday, November 5, 2026, inter-alia, to consider and approve amongst others: 1. The Unaudited Financial Results along with Limited Review Report of the Statutory Auditors thereon of the Company for the 2nd quarter and half year ended on September 30, 2026. 2. The declaration of interim dividend for the FY 2026-27, if any, on the equity share capital of the company. Further, in continuation of our letter dated September 28, 2026, regarding closure of trading window for the aforesaid purpose, the Trading Window for trading in Company's securities will continue to remain closed till November 7, 2026 (until expiry of 48 hours after the un-published price sensitive information are submitted to the Stock Exchanges) in terms of the Company’s “Code of Conduct for Prevention of Insider Trading” The above notice is also available on the Company’s website at https://ilshospitals.com Kindly take the aforesaid information on record and oblige. For GPT Healthcare Limited Ankur Sharma Company Secretary and Compliance Officer M. No A31833